42 devices · GMDN 53313
Glycated haemoglobin (HbA1c) IVD kits using liquid chromatography measure long-term blood glucose levels by detecting HbA1c in clinical samples. Clinicians rely on these devices to monitor diabetes management, assess glycemic control, and evaluate treatment efficacy over weeks or months.
These kits are typically regulated as in vitro diagnostics (IVDs) and may require validation or clearance depending on jurisdiction. They are supplied as reagent kits for laboratory use, often requiring specialized equipment like high-performance liquid chromatography (HPLC) systems for accurate HbA1c quantification.
This category summary is AI-generated from the GMDN nomenclature and has not been verified by a human reviewer.